Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-28 5:08 pm Sale | 2024-12-31 | 13G | CG Oncology, Inc. Common stock CGON | Unique Diamond Investments Limited | 4,211,341 5.500% | -1,343,955 (-24.19%) | Filing History |
| 2024-11-12 2:30 pm Unchanged | 2024-09-30 | 13G | CG Oncology, Inc. Common stock CGON | VANGUARD GROUP INC | 5,081,352 7.570% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | CG Oncology, Inc. Common stock CGON | BlackRock Inc. BLK | 3,570,927 5.300% | 0 (Unchanged) | Filing History |
| 2024-11-04 10:22 am Purchase | 2024-09-30 | 13G | CG Oncology, Inc. Common stock CGON | VANGUARD GROUP INC | 5,081,352 7.570% | 5,081,352 (New Position) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | CG Oncology, Inc. Common stock CGON | BlackRock Inc. BLK | 3,570,927 5.300% | 3,570,927 (New Position) | Filing History |
| 2024-07-22 4:35 pm Purchase | 2024-06-30 | 13G | CG Oncology, Inc. Common stock CGON | Unique Diamond Investments Limited | 5,555,296 8.300% | 5,555,296 (New Position) | Filing History |
| 2024-04-09 7:12 pm Purchase | 2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON | Decheng Capital Global Life Sciences Fund IV L.P. | 5,458,810 8.200% | 400,000 (+7.91%) | Filing History |
| 2024-03-14 7:25 pm Purchase | 2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON | Kissei Pharmaceutical Co. Ltd. | 3,543,533 5.300% | 3,543,533 (New Position) | Filing History |
| 2024-02-09 4:31 pm Purchase | 2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON | TCG Crossover GP I LLC | 3,570,206 5.400% | 3,570,206 (New Position) | Filing History |
| 2024-02-08 5:17 pm Purchase | 2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON | Decheng Capital Global Life Sciences Fund IV L.P. | 5,058,810 7.600% | 5,058,810 (New Position) | Filing History |
| 2024-02-05 4:40 pm Purchase | 2024-01-29 | 13G | CG Oncology, Inc. Common stock CGON | Longitude Capital Partners IV LLC | 4,662,281 7.000% | 4,662,281 (New Position) | Filing History |
| 2024-02-05 3:15 pm Purchase | 2024-01-24 | 13G | CG Oncology, Inc. Common stock CGON | Foresite Capital Fund V L.P. | 3,595,203 5.700% | 3,595,203 (New Position) | Filing History |